Indirect Comparison Analysis of FDA-Approved Treatment Options for Adults with Aquaporin-4 Immunoglobulin G-positive Neuromyelitis Optica Spectrum Disorder

被引：0
|
作者：
Wingerchuk, Dean [1 ]
Pittock, Sean [1 ]
Levy, Michael [2 ]
Fujihara, Kazuo [3 ]
Nakashima, Ichiro [4 ]
Paul, Friedemann [5 ]
Kielhorn, Adrian [6 ]
Royston, Minying [6 ]
Tanvir, Imran [6 ]
Zhang, Ina [7 ]
机构：
[1] Mayo Clin, Rochester, MN USA
[2] Massachusetts Gen Hosp, Boston, MA 02114 USA
[3] Fukushima Med Univ, Fukushima, Japan
[4] Tohoku Med & Pharmaceut Univ Hosp, Dept Neurol, Sendai, Miyagi, Japan
[5] Charite Univ Med Berlin, Berlin, Germany
[6] Alex Pharmaceut, Monksland, Ireland
[7] PRECISIONheor, Los Angeles, CA USA
来源：
NEUROLOGY | 2022年 / 98卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P-15-1.007
引用
收藏
页数：5
相关论文
共 50 条
  • [1] Indirect comparison analysis of FDA-approved treatment options for adults with aquaporin-4 immunoglobulin G-positive neuromyelitis optica spectrum disorder
    Wingerchuk, D.
    Levy, M.
    Fujihara, K.
    Nakashima, I.
    Paul, F.
    Kielhorn, A.
    Royston, M.
    Tanvir, I.
    Zhang, I.
    Pittock, S.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 72 - 72
  • [2] INDIRECT COMPARISON ANALYSIS OF UNITED STATES FOOD AND DRUG ADMINISTRATION-APPROVED TREATMENT OPTIONS FOR ADULTS WITH AQUAPORIN-4 IMMUNOGLOBULIN G-POSITIVE NEUROMYELITIS OPTICA SPECTRUM DISORDER
    Wingerchuk, D.
    Pittock, S. J.
    Levy, M.
    Fujihara, K.
    Nakashima, I
    Paul, F.
    Kielhorn, A.
    Royston, M.
    Tanvir, I
    Zhang, I
    VALUE IN HEALTH, 2022, 25 (01) : S19 - S19
  • [3] Network Meta-analysis of Food and Drug Administration-approved Treatment Options for Adults with Aquaporin-4 Immunoglobulin G-positive Neuromyelitis Optica Spectrum Disorder
    Wingerchuk, Dean M.
    Zhang, Ina
    Kielhorn, Adrian
    Royston, Minying
    Levy, Michael
    Fujihara, Kazuo
    Nakashima, Ichiro
    Tanvir, Imran
    Paul, Friedemann
    Pittock, Sean J.
    NEUROLOGY AND THERAPY, 2022, 11 (01) : 123 - 135
  • [4] Network Meta-analysis of Food and Drug Administration-approved Treatment Options for Adults with Aquaporin-4 Immunoglobulin G-positive Neuromyelitis Optica Spectrum Disorder
    Dean M. Wingerchuk
    Ina Zhang
    Adrian Kielhorn
    Minying Royston
    Michael Levy
    Kazuo Fujihara
    Ichiro Nakashima
    Imran Tanvir
    Friedemann Paul
    Sean J. Pittock
    Neurology and Therapy, 2022, 11 : 123 - 135
  • [5] Letter to the Editor Regarding "Network Meta-analysis of Food and Drug Administration-approved Treatment Options for Adults with Aquaporin-4 Immunoglobulin G-positive Neuromyelitis Optica Spectrum Disorder"
    Cree, Bruce A. C.
    Greenberg, Benjamin
    Cameron, Chris
    Weinshenker, Brian G.
    NEUROLOGY AND THERAPY, 2022, 11 (03) : 1439 - 1443
  • [6] Letter to the Editor Regarding “Network Meta-analysis of Food and Drug Administration-approved Treatment Options for Adults with Aquaporin-4 Immunoglobulin G-positive Neuromyelitis Optica Spectrum Disorder”
    Bruce A. C. Cree
    Benjamin Greenberg
    Chris Cameron
    Brian G. Weinshenker
    Neurology and Therapy, 2022, 11 : 1439 - 1443
  • [7] Evidence of Muller Glial Dysfunction in Patients with Aquaporin-4 Immunoglobulin G-Positive Neuromyelitis Optica Spectrum Disorder
    You, Yuyi
    Zhu, Ling
    Zhang, Ting
    Shen, Ting
    Fontes, Ariadna
    Yiannikas, Con
    Parratt, John
    Barton, Joshua
    Schulz, Angela
    Gupta, Vivek
    Barnett, Michael H.
    Fraser, Clare L.
    Gillies, Mark
    Graham, Stuart L.
    Klistorner, Alexander
    OPHTHALMOLOGY, 2019, 126 (06) : 2019 - 810
  • [8] A Response to: Letter to the Editor Regarding “Network Meta-analysis of Food and Drug Administration-approved Treatment Options for Adults with Aquaporin-4 Immunoglobulin G-positive Neuromyelitis Optica Spectrum Disorder”
    Dean M. Wingerchuk
    Ina Zhang
    Adrian Kielhorn
    Minying Royston
    Michael Levy
    Kazuo Fujihara
    Ichiro Nakashima
    Imran Tanvir
    Friedemann Paul
    Sean J. Pittock
    Neurology and Therapy, 2022, 11 : 1445 - 1449
  • [9] A Response to: Letter to the Editor Regarding "Network Meta-analysis of Food and Drug Administration-approved Treatment Options for Adults with Aquaporin-4 Immunoglobulin G-positive Neuromyelitis Optica Spectrum Disorder"
    Wingerchuk, Dean M.
    Zhang, Ina
    Kielhorn, Adrian
    Royston, Minying
    Levy, Michael
    Fujihara, Kazuo
    Nakashima, Ichiro
    Tanvir, Imran
    Paul, Friedemann
    Pittock, Sean J.
    NEUROLOGY AND THERAPY, 2022, 11 (03) : 1445 - 1449
  • [10] Clinical burden of relapses in aquaporin-4 immunoglobulin G-positive neuromyelitis optica spectrum disorder: A single center cohort analysis
    Kadish, Robert
    Clardy, Stacey L.
    Royston, Minying
    Tanvir, Imran
    Parker, Tavan
    Biskupiak, Joseph
    Kielhorn, Adrian
    JOURNAL OF NEUROIMMUNOLOGY, 2022, 362
12345